What is Viridian Therapeutics, Inc. Common Stock's Market Cap?

Viridian Therapeutics, Inc. Common Stock's Market Cap is $2.6B, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's Price / Sales?

Viridian Therapeutics, Inc. Common Stock's Price / Sales is 36.9×, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's Revenue (TTM)?

Viridian Therapeutics, Inc. Common Stock's Revenue (TTM) is $71.1M, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's Net Income (TTM)?

Viridian Therapeutics, Inc. Common Stock's Net Income (TTM) is -$387.0M, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's EBITDA?

Viridian Therapeutics, Inc. Common Stock's EBITDA is -$404.7M, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Viridian Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.42, based on as-reported figures from SEC (XBRL) filings.

What is Viridian Therapeutics, Inc. Common Stock's EBITDA Margin?

Viridian Therapeutics, Inc. Common Stock's EBITDA Margin is -569.0%, based on as-reported figures from SEC (XBRL) filings.

Viridian Therapeutics, Inc. Common Stock (VRDN) Financial Statements

Viridian Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002H24301

XNAS · usd

23.17▲ 0.25 (1.09%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close22.92

Day's Range22.22 – 23.84

52-Week Range13.18 – 34.29

Volume1.8M

Avg Volume1.5M

Share Statistics

Shares Outstanding

Employees252

ExchangeXNAS

Listed2014-06-18

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Viridian Therapeutics, Inc. Common Stock (VRDN)

What is Viridian Therapeutics, Inc. Common Stock's Market Cap?: Viridian Therapeutics, Inc. Common Stock's Market Cap is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's Price / Sales?: Viridian Therapeutics, Inc. Common Stock's Price / Sales is 36.9×, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's Revenue (TTM)?: Viridian Therapeutics, Inc. Common Stock's Revenue (TTM) is $71.1M, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's Net Income (TTM)?: Viridian Therapeutics, Inc. Common Stock's Net Income (TTM) is -$387.0M, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's EBITDA?: Viridian Therapeutics, Inc. Common Stock's EBITDA is -$404.7M, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Viridian Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.42, based on as-reported figures from SEC (XBRL) filings.
What is Viridian Therapeutics, Inc. Common Stock's EBITDA Margin?: Viridian Therapeutics, Inc. Common Stock's EBITDA Margin is -569.0%, based on as-reported figures from SEC (XBRL) filings.